GeoPharma Announces Second Quarter Earnings Release Date, Annual Meeting, and Research...

GeoPharma Announces Second Quarter Earnings Release Date, Annual Meeting, and
Research Report Availability

LARGO, Fla., Sept. 2, 2008 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX)
(the "Company") announced today that it will release earnings for the second
quarter of fiscal year 2009 on Thursday, November 13, 2008. Earnings will be
released after the close with a conference call to follow.

GeoPharma plans to host its annual meeting on Thursday, October 16, 2008. The
meeting will be held in the Company's corporate headquarters located at 6950
Bryan Dairy Road, Largo, Florida 33777.

Additionally, the Company has made the most recent research reports conducted by
Green Coast Capital, LLC and Red Chip Research available on the Investor
Relations Home page of the GeoPharma website at www.geopharmainc.com.

ABOUT GEOPHARMA, INC.:

GeoPharma, Inc. is a rapidly growing Bio/Pharma company with a diversified
business model participating in 3 main market segments: Specialty Pharma,
Manufacturing, and Distribution. The Specialty Pharma division specializes in
the formulation of generic drugs for human and veterinary usage and the
development of medical devices used by oncologists and other medical
professionals. The Manufacturing and Distribution divisions, manufacture,
package, and distribute generic drugs, nutraceuticals, cosmetics, and functional
food products for companies worldwide.

GeoPharma's growth strategy is to capitalize on its research and manufacturing
expertise to develop medical devices and high margin generic drug products for
niche markets with high barriers to entry. GeoPharma's competitive advantage in
these areas is in its ability to navigate the challenges that such market
pursuits present effectively.

Currently, GeoPharma employs over 300 people and operates facilities in Florida,
Maryland, Pennsylvania, Nevada, Rhode Island, and Texas utilizing over 330,000
sq. ft. of office, warehouse, manufacturing and laboratory facilities.

For further information visit the GeoPharma website at www.geopharmainc.com.

The GeoPharma, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=5384

FORWARD-LOOKING STATEMENTS

This press release may contain statements, which constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995, including those regarding the company and its subsidiaries' expectations,
intentions, strategies and beliefs pertaining to future performance. All
statements contained herein are based upon information available to the
company's management as of the date hereof, and actual results may vary based
upon future events, both within and without management's control. Important
factors that could cause such differences are described in the company's
periodic filings with the Securities and Exchange Commission.

-0-
CONTACT: GeoPharma, Inc.
Alexander Nachman, Director of Investor and Media Relations
1-727-471-0850, ext. 243
IR@GeoPharmainc.com